- Home
- DEVS vs CSCI Comparison
DEVS vs CSCI Comparison
Compare DEVS & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEVS
- CSCI
- Stock Information
- Founded
- DEVS N/A
- CSCI 1990
- Country
- DEVS Canada
- CSCI Canada
- Employees
- DEVS N/A
- CSCI N/A
- Industry
- DEVS
- CSCI
- Sector
- DEVS
- CSCI
- Exchange
- DEVS NYSE
- CSCI NYSE
- Market Cap
- DEVS 11.9M
- CSCI 10.6M
- IPO Year
- DEVS N/A
- CSCI 1996
- Fundamental
- Price
- DEVS $0.34
- CSCI $3.53
- Analyst Decision
- DEVS
- CSCI
- Analyst Count
- DEVS 0
- CSCI 0
- Target Price
- DEVS N/A
- CSCI N/A
- AVG Volume (30 Days)
- DEVS 524.3K
- CSCI 2.5K
- Earning Date
- DEVS 07-22-2025
- CSCI 08-12-2025
- Dividend Yield
- DEVS N/A
- CSCI N/A
- EPS Growth
- DEVS N/A
- CSCI N/A
- EPS
- DEVS N/A
- CSCI N/A
- Revenue
- DEVS $10,164.00
- CSCI $9,030,000.00
- Revenue This Year
- DEVS N/A
- CSCI N/A
- Revenue Next Year
- DEVS N/A
- CSCI N/A
- P/E Ratio
- DEVS N/A
- CSCI N/A
- Revenue Growth
- DEVS N/A
- CSCI 36.51
- 52 Week Low
- DEVS $0.18
- CSCI $1.96
- 52 Week High
- DEVS $3.00
- CSCI $7.18
- Technical
- Relative Strength Index (RSI)
- DEVS N/A
- CSCI N/A
- Support Level
- DEVS N/A
- CSCI N/A
- Resistance Level
- DEVS N/A
- CSCI N/A
- Average True Range (ATR)
- DEVS 0.00
- CSCI 0.00
- MACD
- DEVS 0.00
- CSCI 0.00
- Stochastic Oscillator
- DEVS 0.00
- CSCI 0.00
About DEVS DEVVSTREAM CORP
DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.